All Stories

  1. Phylogenesys and homology modeling in Zika virus epidemic: food for thought
  2. New sepsis biomarkers
  3. Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis
  4. Total HIV-1 DNA
  5. Phylogenetic analysis of human immunodeficiency virus type 2 group B
  6. Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents
  7. Microbiological Infections in Women With Cervical Cytological Reports of Atypical Squamous Cells of Undetermined Significance
  8. Platelet-rich plasma as treatment for persistent ocular epithelial defects
  9. Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: Comparison with the HPV Sign® Genotyping Test
  10. One-year follow-up of patients with long-lasting post-herpetic neuralgia
  11. Nucleotide polymorphisms in the 5′-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype
  12. The human polyomaviruses KI and WU: virological background and clinical implications
  13. An HIV-2 case series in Italy: a phylogenetic analysis
  14. The novel KI, WU and MC polyomaviruses and human diseases
  15. Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients
  16. Molecular analysis of hepatitis B virus in Bulgaria
  17. Phylogeographic Reconstruction of HIV Type 1B in Montenegro and the Balkan Region
  18. HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
  19. Corrigendum to “Human papillomaviruses 53 and 66: Clinical aspects and genetic analysis” [Virus Res. 163 (2012) 212–222]
  20. Human metapneumovirus‐associated hospital admissions over five consecutive epidemic seasons: Evidence for alternating circulation of different genotypes
  21. Phylogeny and phylodinamic of Hepatitis C in Italy
  22. Human polyomaviruses identification by logic mining techniques
  23. Performance evaluation of the Artus hepatitis C virus QS-RGQ assay
  24. Human papillomaviruses 53 and 66: Clinical aspects and genetic analysis
  25. A Case of Italian HIV Type 2 Infection: A Genetic Analysis
  26. Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
  27. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology
  28. Genetic Diversity of HIV Type 1 in Montenegro
  29. Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users
  30. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: A comparative study
  31. Phylogenesis and Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
  32. KI and WU Polyomaviruses and CD4+ Cell Counts in HIV-1–infected Patients, Italy
  33. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis
  34. A multicenter evaluation of the Abbott RealTime HCV Genotype II assay
  35. KI and WU Polyomavirus detection in tonsils of immunocompetent patients
  36. Genetic variability of the small t antigen of the novel KI, WU and MC polyomaviruses
  37. Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients
  38. A multicenter evaluation of the Abbott RealTime HCV genotype II assay
  39. Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007
  40. Real Time PCR TaqMan assays for detection of polyomaviruses KIV and WUV in clinical samples
  41. Identification of the novel KI and WU polyomaviruses in human tonsils
  42. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions
  43. Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders
  44. KI and WU Polyomaviruses in Patients Infected with HIV-1, Italy
  45. Origin of the 2009 Mexico influenza virus: a comparative phylogenetic analysis of the principal external antigens and matrix protein
  46. Identification of the novel KI Polyomavirus in paranasal and lung tissues
  47. Proteomic Investigation in A549 Lung Cell Line Stably Infected by HPV16E6/E7 Oncogenes
  48. Identification of the novel KI polyomavirus in the respiratory tract of an Italian patient
  49. Corrigendum to “Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis” [Gynecol. Oncol. 108 (2008) 112–120]
  50. Predicting High-Risk Human Papillomavirus Infection, Progression of Cervical Intraepithelial Neoplasia, and Prognosis of Cervical Cancer With a Panel of 13 Biomarkers Tested in Multivariate Modeling
  51. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis
  52. Impact of storage conditions on genetic analysis or viral load determination in clinical specimens
  53. Co-Expression of HSV2 and Chlamydia trachomatis in HPV-Positive Cervical Cancer and Cervical Intraepithelial Neoplasia Lesions Is Associated with Aberrations in Key Intracellular Pathways
  54. Clinical and epidemiological correlates of antibody response to Human Papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens
  55. Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma
  56. Prevalence and genotyping of human papillomavirus infection in women with vulvodynia
  57. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation
  58. Over-Expression of Topoisomerase II?? is Related to the Grade of Cervical Intraepithelial Neoplasia (CIN) and High-Risk Human Papillomavirus (HPV), but does not Predict Prognosis in Cervical Cancer or HPV Clearance after Cone Treatment
  59. A novel mutation of varicella-zoster virus associated to fatal hepatitis
  60. Single or multiple HPV types in cervical cancer and associated metastases
  61. Relationship of Up-Regulation of 67-kd Laminin Receptor to Grade of Cervical Intraepithelial Neoplasia and to High-Risk HPV Types and Prognosis in Cervical Cancer
  62. Survivin as a Marker of Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus and a Predictor of Virus Clearance and Prognosis in Cervical Cancer
  63. Activation of the ERK/MAP Kinase Pathway in Cervical Intraepithelial Neoplasia Is Related to Grade of the Lesion but Not to High-Risk Human Papillomavirus, Virus Clearance, or Prognosis in Cervical Cancer
  64. Activation of the ERK/MAP Kinase Pathway in Cervical Intraepithelial Neoplasia Is Related to Grade of the Lesion but not to High-Risk Human Papillomavirus, Virus Clearance, or Prognosis in Cervical Cancer
  65. Follicle-stimulating hormone, testosterone, and hypoxia differentially regulate UDP-glucuronosyltransferase 1 isoforms expression in rat Sertoli and peritubular myoid cells
  66. Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis?
  67. Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38) by the Human UDP-Glucuronosyltransferases Encoded at the UGT1 Locus
  68. Delayed Response to Phenobarbital Treatment of a Crigler-Najjar Type II Patient with Partially Inactivating Missense Mutations in the Bilirubin UDP-Glucuronosyltransferase Gene
  69. Required Buried α-Helical Structure in the Bilirubin UDP-Glucuronosyltransferase, UGT1A1, Contains a Nonreplaceable Phenylalanine
  70. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications
  71. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis
  72. Genetic defects at the UGT1 locus associated with Crigler‐Najjar type I disease, including a prenatal diagnosis
  73. 9 Pathogens relevant in transplantation medicine
  74. 9. Pathogens relevant in transplantation medicine